Want to see AU:DVL full AI Analyst Report?
Top Page
dorsaVi Limited
(Sydney:DVL)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.02
â–²(0.00% Upside)
Action:Reiterated
Date:09/15/26
The score is held down primarily by weak financial performance—persistent losses, a sharp profitability deterioration in 2026, and ongoing negative operating/free cash flow. Technical indicators add a negative tilt with the stock trading below longer-term moving averages and a negative MACD. Valuation provides limited support due to negative earnings (negative P/E) and no dividend yield data.
Positive Factors
Digital health product platform
The combination of wearable hardware and software creates a focused digital-health platform with applications across clinical assessment, rehabilitation, physiotherapy, and occupational health. Objective movement data can support professional decision-making and provides a durable basis for serving multiple healthcare and workplace use cases.
Negative Factors
Volatile, declining revenue
The long-term decline and volatility in revenue indicate that commercial adoption has not yet developed into a consistent growth engine. An isolated rebound does not remove the broader trend, leaving the company with less operating scale and making sustained investment and profitability harder to achieve.
Read all positive and negative factors
Positive Factors
Negative Factors
Digital health product platform
The combination of wearable hardware and software creates a focused digital-health platform with applications across clinical assessment, rehabilitation, physiotherapy, and occupational health. Objective movement data can support professional decision-making and provides a durable basis for serving multiple healthcare and workplace use cases.
Read all positive factors
dorsaVi Limited (DVL) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$28.79M
Dividend YieldN/A
Average Volume (3M)451.29K
Price to Earnings (P/E)―
Beta (1Y)1.94
Revenue Growth-11.13%
EPS Growth-280.00%
CountryAU
Employees34
SectorTechnology
Sector Strength88
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,370,937,500
10 Day Avg. Volume166,838
30 Day Avg. Volume451,287
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)9.06
Price to Sales (P/S)39.12
P/FCF Ratio-7.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
dorsaVi Limited Business Overview & Revenue Model
Company Description
dorsaVi Ltd, an Australian company established in 2008 and based in Oakleigh South, focuses on creating and distributing advanced motion analysis technologies throughout Australia, Europe, and the United States. Its product portfolio includes ViMo...
How the Company Makes Money
null...
dorsaVi Limited Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
24
Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.00M | 1.13M | 1.30M | 1.75M | 2.35M |
| Gross Profit | -3.33M | 971.82K | 1.18M | -798.43K | -1.45M |
| EBITDA | -7.36M | -1.82M | -1.60M | -1.88M | -1.53M |
| Net Income | -8.52M | -1.52M | -1.25M | -1.82M | -1.54M |
Balance Sheet | |||||
| Total Assets | 5.85M | 3.97M | 2.18M | 2.69M | 3.36M |
| Cash, Cash Equivalents and Short-Term Investments | 2.12M | 2.29M | 478.10K | 878.72K | 449.70K |
| Total Debt | 68.25K | 156.89K | 190.17K | 321.85K | 1.18M |
| Total Liabilities | 1.51M | 1.14M | 1.16M | 1.01M | 2.13M |
| Stockholders Equity | 4.34M | 2.84M | 1.02M | 1.68M | 1.22M |
Cash Flow | |||||
| Free Cash Flow | -5.28M | -956.83K | -622.08K | -1.02M | -2.25M |
| Operating Cash Flow | -5.28M | -956.83K | -600.90K | -967.41K | -2.15M |
| Investing Cash Flow | -5.64K | -304.00K | -21.18K | -51.65K | -100.34K |
| Financing Cash Flow | 5.12M | 3.08M | 227.06K | 1.45M | -92.25K |
dorsaVi Limited Technical Analysis
Negative
0.02
Price Trends
0.02
Negative
0.03
Negative
0.03
Negative
Market Momentum
>-0.01
Negative
44.91
Neutral
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DVL, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 44.91 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DVL.
dorsaVi Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | AU$1.03B | -16.25 | -15.51% | ― | 19.02% | -140.54% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
45 Neutral | AU$10.38M | -0.59 | 136.97% | ― | 38.17% | 83.44% | |
44 Neutral | AU$5.10M | -3.47 | -247.44% | ― | 17.51% | 43.31% | |
43 Neutral | AU$28.79M | -2.76 | -165.14% | ― | -11.13% | -280.00% | |
43 Neutral | AU$33.09M | -4.05 | -23.77% | ― | 10.62% | 36.67% | |
42 Neutral | AU$50.56M | -3.69 | -92.06% | ― | ― | ― |
* Technology Sector Average
AU:DVL
dorsaVi Limited
0.02
-0.03
-58.00%
AU:CAT
Catapult Group International
3.38
-3.34
-49.70%
AU:X2M
X2M Connect Limited
0.01
<0.01
20.00%
AU:VR1
Vection Technologies Ltd.
0.02
-0.03
-64.29%
AU:AUA
Audeara Ltd.
0.02
>-0.01
-25.00%
AU:NVU
Nanoveu Ltd.
0.05
-0.04
-45.35%
dorsaVi Limited Corporate Events
DorsaVi Sets 2026 AGM to Confirm Board, Auditor and Capital Raising
Oct 30, 2026
DorsaVi Ltd, a Melbourne-based wearable sensor and motion analysis specialist, serves healthcare, workplace safety, and sports performance markets with technology that measures and analyses human movement. The company leverages its data-driven bio...
DorsaVi Clears Trading for 135.9 Million New Shares with Section 708A Notice
Oct 23, 2026
DorsaVi has issued 131,818,181 fully paid ordinary shares in line with its earlier capital raising announcement, along with 4,090,909 shares to settle placement fees, bringing the total new share issuance to 135,909,090. The company has lodged a S...
DorsaVi Issues New Tranche of Unlisted Long-Dated Options
Oct 23, 2026
DorsaVi Ltd has notified the market of a new issue of 2,045,455 unquoted options, exercisable at $0.045 and expiring on 23 October 2029, under its latest Appendix 3G filing with the ASX. The options issuance, dated 23 October 2026, modestly expand...
DorsaVi Issues 65.9 Million Unquoted Options in Capital Management Move
Oct 23, 2026
DorsaVi Ltd has notified the market of the issue of 65,909,090 unquoted options, exercisable at $0.045 and expiring on October 23, 2029. The options form part of previously announced transactions and are not intended to be quoted on the ASX, indic...
dorsaVi Seeks ASX Quotation for 131.8 Million New Shares
Oct 23, 2026
dorsaVi Ltd has applied to the ASX for quotation of 131,818,181 new ordinary fully paid shares under code DVL, with an issue date of 23 October 2026. The large volume of new securities, issued pursuant to a previously announced transaction, points...
dorsaVi launches Sensor v6.5 as RRAM chip fabrication advances
Oct 22, 2026
dorsaVi commercially launched Sensor v6.5, its first wearable device that can measure movement, analyse patterns linked to injury risk, decide on appropriate responses and deliver configurable haptic, audible or visual biofeedback directly on-sens...
dorsaVi sets November date for AGM as it advances ultra-edge strategy
Oct 12, 2026
dorsaVi Ltd has scheduled its 2026 Annual General Meeting for 30 November 2026, with a 19 October 2026 deadline for shareholders or other parties to nominate candidates for election to the board. The meeting timetable underscores standard governan...
dorsaVi Plans Major Equity Issue to Boost Capital Base
Oct 5, 2026
dorsaVi Ltd has outlined plans for a new capital raise via a proposed issue of securities on the ASX, including up to 136,363,636 fully paid ordinary shares and 68,181,818 unlisted options exercisable at $0.045, expiring three years from the issue...
DorsaVi Plans Issue of 24 Million Unlisted Options on ASX
Oct 5, 2026
DorsaVi Ltd has notified the ASX of a proposed issue of securities in the form of 24 million unlisted options, exercisable at $0.045 and expiring three years from the date of issue. The options, to be issued on 19 October 2026, will be created as ...
DorsaVi Raises A$3 Million to Accelerate Physical AI and Humanoid Robotics Strategy
Oct 5, 2026
DorsaVi Limited has secured firm commitments to raise A$3 million via a placement to high-net-worth and other sophisticated investors, issuing new shares at A$0.022 each to bolster its strategic shift toward Physical AI and advanced robotics. The ...
dorsaVi Seeks Trading Halt Ahead of Proposed Capital Raising
Oct 1, 2026
dorsaVi Limited, an ASX-listed company based in Perth and trading under the ticker DVL, operates in the public capital markets and uses equity raisings as part of its funding strategy. Although the release does not elaborate on its specific produc...
dorsaVi pivots movement data and neuromorphic tech toward humanoid robotics
Sep 20, 2026
dorsaVi Limited is leveraging its long-established movement data library, wearable sensors and Video AI capabilities, which span clinical, workplace, sporting and animal applications, to move beyond its traditional sensor markets. The company also...
dorsaVi Advances Energy-Efficient RRAM for Physical AI and Robotics
Sep 13, 2026
dorsaVi Limited has begun specialised electrical measurements to characterise the energy required to update states in its engineered resistive random-access memory structures, a crucial metric for its low-power RRAM-CMOS hardware roadmap. The devi...
DorsaVi widens annual loss but boosts net assets through capital raisings and new licences
Aug 31, 2026
DorsaVi Limited reported a 5.8% increase in revenue to $1.59 million for the year ended 30 June 2026, but its loss after tax surged to $8.52 million, more than five times the prior year, with no dividends declared. Despite the deeper loss and an a...
dorsaVi Starts Fabrication of First RRAM-CMOS Validation Chip
Aug 11, 2026
dorsaVi Limited has begun silicon fabrication of its first RRAM-CMOS validation chip, with the manufacturing data package accepted into a semiconductor foundry’s production flow and wafer processing now underway. This marks a significant shi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.